Search

Your search keyword '"Jensen, H.E."' showing total 329 results
Start Over Author "Jensen, H.E."
329 results on '"Jensen, H.E."'

7. Skin ulcerations in danish nursery pigs

Author

Barington, K., primary, Pankoke, K., additional, Hartmann, K.T., additional, Hansen, M.S., additional, Jensen, H.E., additional, Blirup-Plum, S.A., additional, Jørgensen, B.M., additional, Nielsen, J.P., additional, Eriksen, E.Ø., additional, Kudirkiene, E., additional, Olsen, J.E., additional, and Pedersen, K.S., additional

Published
2024
Full Text
View/download PDF

15. ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

Author

Cornely, O.A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B.J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M.C., Arikan-Akdagli, S., Bille, J., Castagnola, E., Cuenca-Estrella, M., Donnelly, J.P., Groll, A.H., Herbrecht, R., Hope, W.W., Jensen, H.E., Lass-Florl, C., Petrikkos, G., Richardson, M.D., Roilides, E., Verweij, P.E., Viscoli, C., and Ullmann, A.J.

Published
2012
Full Text
View/download PDF

16. ESCMID guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.

Author

Hope, W.W., Castagnola, E., Groll, A.H., Roilides, E., Akova, M., Arendrup, M.C., Arikan-Akdagli, S., Bassetti, M., Bille, J., Cornely, O.A., Cuenca-Estrella, M., Donnelly, J.P., Garbino, J., Herbrecht, R., Jensen, H.E., Kullberg, B.J., Lass-Flörl, C., Lortholary, O., Meersseman, W., Petrikkos, G., Richardson, M.D., Verweij, P.E., Viscoli, C., and Ullmann, A.J.

Published
2012
Full Text
View/download PDF

17. ESCMID guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS

Author

Lortholary, O., Petrikkos, G., Akova, M., Arendrup, M.C., Arikan-Akdagli, S., Bassetti, M., Bille, J., Calandra, T., Castagnola, E., Cornely, O.A., Cuenca-Estrella, M., Donnelly, J.P., Garbino, J., Groll, A.H., Herbrecht, R., Hope, W.W., Jensen, H.E., Kullberg, B.J., Lass-Flörl, C., Meersseman, W., Richardson, M.D., Roilides, E., Verweij, P.E., Viscoli, C., and Ullmann, A.J.

Published
2012
Full Text
View/download PDF

18. ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)

Author

Ullmann, A.J., Akova, M., Herbrecht, R., Viscoli, C., Arendrup, M.C., Arikan-Akdagli, S., Bassetti, M., Bille, J., Calandra, T., Castagnola, E., Cornely, O.A., Donnelly, J.P., Garbino, J., Groll, A.H., Hope, W.W., Jensen, H.E., Kullberg, B.J., Lass-Flörl, C., Lortholary, O., Meersseman, W., Petrikkos, G., Richardson, M.D., Roilides, E., Verweij, P.E., and Cuenca-Estrella, M.

Published
2012
Full Text
View/download PDF

19. ESCMID guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases

Author

Ullmann, A.J., Cornely, O.A., DonneNy, J.P., Akova, M., Arendrup, M.C., Arikan-Akdagli, S., Bassetti, M., Bille, J., Calandra, T., Castagnola, E., Garbino, J., Groll, A.H., Herbrecht, R., Hope, W.W., Jensen, H.E., Kullberg, B.J., Lass-Flörl, C., Lortholary, O., Meersseman, W., Petrikkos, G., Richardson, M.D., Roilides, E., Verweij, P.E., Viscoli, C., and Cuenca-Estrella, M.

Published
2012
Full Text
View/download PDF

29. Tillage-induced horizontal periodicity of preferential flow in the root zone

Author

Petersen, C.T., Hansen, S., and Jensen, H.E.

Subjects
Groundwater flow -- Analysis, Roots (Botany) -- Analysis, Tillage -- Analysis, Earth sciences
Abstract

Flow patterns for water and solutes in the root zone are often heterogeneous. Understanding the spatial variability of flow is essential in solute-transport studies and for management of chemical movement. We hypothesized the occurrence of effects of past tillage operations (plowing and seed bed preparation with and without rotovation) on flow patterns and that such effects could he determined from dye tracing. High-resolution, digitized images of flow patterns on 221 vertical soil profiles (1 [m.sup.2]) perpendicular to the direction of plowing in two sandy loam soils (Typic Agrudalfs) were analyzed using time series analysis. Significant (P [less than] 0.01) horizontal periodicity with a characteristic length equal to the furrow width for the plow (35 cm) was found for the degree of dye coverage in the 0- to 25-cm topsoil layer (12 out of 15 plots) and for the number of stained channels in the 25- to 100-cm subsoil layer (11 out of 15 plots) after plowing and conventional seed bed preparation (harrowing). The 35-cm-scale periodic variability of flow patterns in the subsoil was linearly related to the variability of patterns in the topsoil in three out of 17 plots (P < 0.01). Significant (P < 0.05) linear trends with horizontal distance were found for the degree of dye coverage in the topsoil (11 out of 20 plots), and for the number of stained channels in the subsoil (10 out of 17 plots). Rotovating after seedbed harrowing (five plots) reduced the number of stained flow pathways in the subsoil.

Published
1997

30. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

Author

Donnelly, J.P., Chen, S.C., Kauffman, C.A., Steinbach, W.J., Baddley, J.W., Verweij, P.E., Clancy, C.J., Wingard, J.R., Lockhart, S.R., Groll, A.H., Sorrell, T.C., Bassetti, M., Akan, H., Alexander, B.D., Andes, D., Azoulay, E., Bialek, R., Bradsher, R.W., Bretagne, S., Calandra, T., Caliendo, A.M., Castagnola, E., Cruciani, M., Cuenca-Estrella, M., Decker, C.F., Desai, S.R., Fisher, B., Harrison, T., Heussel, C.P., Jensen, H.E., Kibbler, C.C., Kontoyiannis, D.P., Kullberg, B.J., Lagrou, K., Lamoth, F., Lehrnbecher, T., Loeffler, J., Lortholary, O., Maertens, J., Marchetti, O., Marr, K.A., Masur, H., Meis, J.F.G.M., Morrisey, C.O., Nucci, M., Ostrosky-Zeichner, L., Pagano, L., Patterson, T.F., Perfect, J.R., Racil, Z., Roilides, E., Ruhnke, M., Schaefer-Prokop, C.M., Shoham, S., Slavin, M.A., Stevens, David A., Thompson, G.R., Vazquez, J.A., Viscoli, C., Walsh, T.J., Warris, A., Wheat, L.J., White, P.L., Zaoutis, T.E., Pappas, P.G., Donnelly, J.P., Chen, S.C., Kauffman, C.A., Steinbach, W.J., Baddley, J.W., Verweij, P.E., Clancy, C.J., Wingard, J.R., Lockhart, S.R., Groll, A.H., Sorrell, T.C., Bassetti, M., Akan, H., Alexander, B.D., Andes, D., Azoulay, E., Bialek, R., Bradsher, R.W., Bretagne, S., Calandra, T., Caliendo, A.M., Castagnola, E., Cruciani, M., Cuenca-Estrella, M., Decker, C.F., Desai, S.R., Fisher, B., Harrison, T., Heussel, C.P., Jensen, H.E., Kibbler, C.C., Kontoyiannis, D.P., Kullberg, B.J., Lagrou, K., Lamoth, F., Lehrnbecher, T., Loeffler, J., Lortholary, O., Maertens, J., Marchetti, O., Marr, K.A., Masur, H., Meis, J.F.G.M., Morrisey, C.O., Nucci, M., Ostrosky-Zeichner, L., Pagano, L., Patterson, T.F., Perfect, J.R., Racil, Z., Roilides, E., Ruhnke, M., Schaefer-Prokop, C.M., Shoham, S., Slavin, M.A., Stevens, David A., Thompson, G.R., Vazquez, J.A., Viscoli, C., Walsh, T.J., Warris, A., Wheat, L.J., White, P.L., Zaoutis, T.E., and Pappas, P.G.

Abstract

Contains fulltext : 225781.pdf (Publisher’s version ) (Open Access), BACKGROUND: Invasive fungal diseases (IFDs) remain important causes of morbidity and mortality. The consensus definitions of the Infectious Diseases Group of the European Organization for Research and Treatment of Cancer and the Mycoses Study Group have been of immense value to researchers who conduct clinical trials of antifungals, assess diagnostic tests, and undertake epidemiologic studies. However, their utility has not extended beyond patients with cancer or recipients of stem cell or solid organ transplants. With newer diagnostic techniques available, it was clear that an update of these definitions was essential. METHODS: To achieve this, 10 working groups looked closely at imaging, laboratory diagnosis, and special populations at risk of IFD. A final version of the manuscript was agreed upon after the groups' findings were presented at a scientific symposium and after a 3-month period for public comment. There were several rounds of discussion before a final version of the manuscript was approved. RESULTS: There is no change in the classifications of "proven," "probable," and "possible" IFD, although the definition of "probable" has been expanded and the scope of the category "possible" has been diminished. The category of proven IFD can apply to any patient, regardless of whether the patient is immunocompromised. The probable and possible categories are proposed for immunocompromised patients only, except for endemic mycoses. CONCLUSIONS: These updated definitions of IFDs should prove applicable in clinical, diagnostic, and epidemiologic research of a broader range of patients at high-risk.

Published
2020

35. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

Author

Cornely, O.A. Alastruey-Izquierdo, A. Arenz, D. Chen, S.C.A. Dannaoui, E. Hochhegger, B. Hoenigl, M. Jensen, H.E. Lagrou, K. Lewis, R.E. Mellinghoff, S.C. Mer, M. Pana, Z.D. Seidel, D. Sheppard, D.C. Wahba, R. Akova, M. Alanio, A. Al-Hatmi, A.M.S. Arikan-Akdagli, S. Badali, H. Ben-Ami, R. Bonifaz, A. Bretagne, S. Castagnola, E. Chayakulkeeree, M. Colombo, A.L. Corzo-León, D.E. Drgona, L. Groll, A.H. Guinea, J. Heussel, C.-P. Ibrahim, A.S. Kanj, S.S. Klimko, N. Lackner, M. Lamoth, F. Lanternier, F. Lass-Floerl, C. Lee, D.-G. Lehrnbecher, T. Lmimouni, B.E. Mares, M. Maschmeyer, G. Meis, J.F. Meletiadis, J. Morrissey, C.O. Nucci, M. Oladele, R. Pagano, L. Pasqualotto, A. Patel, A. Racil, Z. Richardson, M. Roilides, E. Ruhnke, M. Seyedmousavi, S. Sidharthan, N. Singh, N. Sinko, J. Skiada, A. Slavin, M. Soman, R. Spellberg, B. Steinbach, W. Tan, B.H. Ullmann, A.J. Vehreschild, J.J. Vehreschild, M.J.G.T. Walsh, T.J. White, P.L. Wiederhold, N.P. Zaoutis, T. Chakrabarti, A. Mucormycosis ECMM MSG Global Guideline Writing Group

Abstract

Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality. Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and medical intervention is lifesaving. Guidance on the complex multidisciplinary management has potential to improve prognosis, but approaches differ between health-care settings. From January, 2018, authors from 33 countries in all United Nations regions analysed the published evidence on mucormycosis management and provided consensus recommendations addressing differences between the regions of the world as part of the “One World One Guideline” initiative of the European Confederation of Medical Mycology (ECMM). Diagnostic management does not differ greatly between world regions. Upon suspicion of mucormycosis appropriate imaging is strongly recommended to document extent of disease and is followed by strongly recommended surgical intervention. First-line treatment with high-dose liposomal amphotericin B is strongly recommended, while intravenous isavuconazole and intravenous or delayed release tablet posaconazole are recommended with moderate strength. Both triazoles are strongly recommended salvage treatments. Amphotericin B deoxycholate is recommended against, because of substantial toxicity, but may be the only option in resource limited settings. Management of mucormycosis depends on recognising disease patterns and on early diagnosis. Limited availability of contemporary treatments burdens patients in low and middle income settings. Areas of uncertainty were identified and future research directions specified. © 2019 Elsevier Ltd

Published
2019

49. ESCMID Diagnostic and management guideline for Candida diseases 2012: Developing European guidelines in clinical microbiology and infectious diseases

Author

Ullman, A.J., Cornely, O.A., Donnelly, P., Akova, M., Arendrup, M.C., Arikan-Akdagli, S., Bassetti, M., Bille, J., Calandra, T, Castagnola, E., Garbino, J., Groll, A., Herbrecht, R., Hope, W., Jensen, H.E., Kullberg, B.J., Lass-Flörl, C., Lortholary, O., Meersseman, W., Petrikkos, G., Richardson, M., Roilides, E., Verweij, P.E., Viscoli, C., and Cuenca-Estrella, M.

Subjects
Invasive mycoses and compromised host Translational research [N4i 2], Invasive mycoses and compromised host Infection and autoimmunity [N4i 2]
Abstract

Item does not contain fulltext

Published
2012

50. ESCMID guideline for the diagnosis and management of Candida diseases 2012: Patients with HIV infection or AIDS

Author

Lortholary, O. Petrikkos, G. Akova, M. Arendrup, M.C. Arikan-Akdagli, S. Bassetti, M. Bille, J. Calandra, T. Castagnola, E. Cornely, O.A. Cuenca-Estrella, M. Donnelly, J.P. Garbino, J. Groll, A.H. Herbrecht, R. Hope, W.W. Jensen, H.E. Kullberg, B.J. Lass-Flörl, C. Meersseman, W. Richardson, M.D. Roilides, E. Verweij, P.E. Viscoli, C. Ullmann, A.J.

Abstract

Mucosal candidiasis is frequent in immunocompromised HIV-infected highly active antiretroviral (HAART) naive patients or those who have failed therapy. Mucosal candidiasis is a marker of progressive immune deficiency. Because of the frequently marked and prompt immune reconstitution induced by HAART, there is no recommendation for primary antifungal prophylaxis of mucosal candidiasis in the HIV setting in Europe, although it has been evidenced as effective in the pre-HAART era. Fluconazole remains the first line of therapy for both oropharyngeal candidiasis and oesophageal candidiasis and should be preferred to itraconazole oral solution (or capsules when not available) due to fewer side effects. For patients who still present with fluconazole-refractory mucosal candidiasis, oral treatment with any other azole should be preferred based on precise Candida species identification and susceptibility testing results in addition to the optimization of HAART when feasible. For vaginal candidiasis, topical therapy is preferred. © 2012 The Authors. Clinical Microbiology and Infection © 2012 European Society of Clinical Microbiology and Infectious Diseases.

Published
2012

Catalog

Books, media, physical & digital resources
See catalog results